Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Immune Deficiency”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Large-scale testing (Phase 3)Study completedNCT02227238
What this trial is testing

Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment

Who this might be right for
HIV Infections
ViiV Healthcare 627
Post-approval studies (Phase 4)Study completedNCT02711228
What this trial is testing

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

Who this might be right for
Primary Immune DeficiencySecondary Immune Deficiency
CSL Behring 26
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableLooking for participantsNCT06989541
What this trial is testing

Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy

Who this might be right for
Hypogammaglobulinemia, Acquired
University of Alberta 30
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Not applicableStudy completedNCT02303093
What this trial is testing

Non-Interventional Study on the Tolerability and Efficacy of IVIG

Who this might be right for
Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
Octapharma 344
Testing effectiveness (Phase 2)Ended earlyNCT00432419
What this trial is testing

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Who this might be right for
HIV InfectionsLymphoma, Non-Hodgkin
French National Agency for Research on AIDS and Viral Hepatitis 1
Not applicableStudy completedNCT01751594
What this trial is testing

Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men

Who this might be right for
HIVAIDS
University of North Carolina, Chapel Hill 92
Post-approval studies (Phase 4)UnknownNCT03017872
What this trial is testing

Dolutegravir and Darunavir Evaluation in Adults Failing Therapy

Who this might be right for
HIV Infections
Kirby Institute 831
Large-scale testing (Phase 3)Study completedNCT03211065
What this trial is testing

Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig

Who this might be right for
Secondary Immune Deficiency
Rochester General Hospital 16
Not applicableStudy completedNCT02888535
What this trial is testing

Intensive Care Unit and Secondary and Primary Immune Deficiency

Who this might be right for
Primary Immune Deficiency Disorder
University Hospital, Caen 16
Not applicableLooking for participantsNCT01666080
What this trial is testing

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Who this might be right for
Hematologic DisordersHemoglobinopathiesImmunodeficiencies
Masonic Cancer Center, University of Minnesota 30
Not applicableStudy completedNCT00856388
What this trial is testing

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more
Roswell Park Cancer Institute 62
Not applicableStudy completedNCT05074251
What this trial is testing

Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV

Who this might be right for
HIV InfectionsARTHIV Seropositivity
University of California, Los Angeles 180
Not applicableStudy completedNCT03778840
What this trial is testing

Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab

Who this might be right for
Autoimmune Diseases
University Hospital, Lille 73
Large-scale testing (Phase 3)Study completedNCT02817451
What this trial is testing

DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 53
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Early research (Phase 1)WithdrawnNCT00886496
What this trial is testing

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+4 more
Enzon Pharmaceuticals, Inc.
Not applicableStudy completedNCT04036097
What this trial is testing

Prospective Stratification of Infectious Risks in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Basel, Switzerland 298
Not applicableStudy completedNCT00005762
What this trial is testing

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Load More Results